Future Science Group

sorry, we can't preview this file

Supplementary Table 1.docx (19.13 kB)

Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study Supplementary Table 1

Download (19.13 kB)
Version 2 2023-03-14, 10:39
Version 1 2023-03-14, 10:39
posted on 2023-03-14, 10:39 authored by Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, Cansu Belge, Ridvan Karahasanoglu, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Nihal Yildirim, Bedriye Kar, Mediha Bozkurt, Kubra Karanalbant, Burcu Atasoy, Hindirin Takak, Serap Simsek-Yavuz, Rustu Turkay, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu

Background: We aimed to explore the prevalence of prolonged symptoms, pulmonary impairments and

residual disease on chest tomography (CT) in COVID-19 patients at 6 months after acute illness. Methods: In

this prospective, single-center study, hospitalized patients with radiologically and laboratory-confirmed

COVID-19 were included. Results: A high proportion of the 116 patients reported persistent symptoms

(n = 54; 46.6%). On follow-up CT, 33 patients (28.4%) demonstrated residual disease. Multivariate analyses

revealed that only neutrophil-to-lymphocyte ratio was an independent predictor for residual disease.

Conclusion: Hospitalized patients with mild/moderate COVID-19 still had persistent symptoms and were

prone to develop long-term pulmonary sequelae on chest CT. However, it did not have a significant effect

on long-term pulmonary functions.


Usage metrics

    Future Microbiology


    Ref. manager